Metraipolis › archive › dc_30b71ce39b3a

Regulatory framework for polymer-based nanotherapeutics in clinical translation — Europe PMC PMID:41647359

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41647359
DOI
10.3389/fbioe.2026.1735885
License (as archived)
solo-consultazione
Archived
2026-11-06T15:21:48.791Z
SHA-256 of the archived text
eca4a50582c48bbd23c7fa9e70a1491058db863316a7b625b1f29d8a353f52f8
Stable URL of this page
https://metraipolis.com/documento/dc_30b71ce39b3a

How to cite

Regulatory framework for polymer-based nanotherapeutics in clinical translation — Europe PMC PMID:41647359 — Europe PMC (en), https://europepmc.org/article/MED/41647359 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_30b71ce39b3a (Metraipolis archive dc_30b71ce39b3a, sha256 eca4a50582c48bbd23c7fa9e70a1491058db863316a7b625b1f29d8a353f52f8)
BibTeX
@misc{dc30b71ce39b3a,
  title = {Regulatory framework for polymer-based nanotherapeutics in clinical translation — Europe PMC PMID:41647359},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41647359},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_30b71ce39b3a; sha256 eca4a50582c48bbd23c7fa9e70a1491058db863316a7b625b1f29d8a353f52f8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41647359. Agents can read the archived copy with the MCP tool read_document.